Skip to main content
Top
Published in: Journal of Bone and Mineral Metabolism 3/2017

01-05-2017 | Letter to the Editor

Decreased rate of hip fracture and consequent reduction in estimated medical costs in Japan

Authors: Hiroaki Ohta, Mitsuko Mouri, Tatsuhiko Kuroda, Toshitaka Nakamura, Masataka Shiraki, Hajime Orimo

Published in: Journal of Bone and Mineral Metabolism | Issue 3/2017

Login to get access

Abstract

The frequency of hip fractures associated with aging of the population is declining in many countries. Even in Japan, where this frequency has been increasing continually, a shift to decreasing frequency has been noted in recent reports. The objective of this study was to investigate the effects of this decrease and to estimate the number of hip fracture patients and the resulting reduction in national medical care expenditures. The differences in the number of patients were estimated by multiplying the population for each sex and each age group by the fracture rates before the decrease (2007) and after the decrease (2012). Total reduced cost was calculated by multiplying the treatment cost required for hip fracture and the annual medical cost of nursing care. The estimated number of hip fracture patients decreased by approximately 4000 in the elderly female population, and the resulting reduction in medical costs was approximately US$280 million. The number of patients with hip fractures has decreased in elderly Japanese women; as a result, the medical costs for treatment and nursing care might decrease.
Literature
1.
go back to reference Statistics Bureau, Ministry of Internal Affairs and Communications, Statistics Japan. Population statistics of Japanese elderly people age 65 years old and over, 15 September 2013 Statistics Bureau, Ministry of Internal Affairs and Communications, Statistics Japan. Population statistics of Japanese elderly people age 65 years old and over, 15 September 2013
2.
go back to reference Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 22:465–475CrossRefPubMed Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 22:465–475CrossRefPubMed
3.
go back to reference Cooper C, Cole ZA, Holroyd CR, Earl SC, Harvey NC, Dennison EM, Melton LJ, Cummings SR, Kanis JA, IOF CSA Working Group on Fracture Epidemiology (2011) Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int 22:1277–1288CrossRefPubMedPubMedCentral Cooper C, Cole ZA, Holroyd CR, Earl SC, Harvey NC, Dennison EM, Melton LJ, Cummings SR, Kanis JA, IOF CSA Working Group on Fracture Epidemiology (2011) Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int 22:1277–1288CrossRefPubMedPubMedCentral
4.
go back to reference Orimo H, Hashimoto T, Sakata K, Yoshimura N, Suzuki T, Hosoi T (2000) Trends in the incidence of hip fracture in Japan, 1987–1997: the third nationwide survey. J Bone Miner Metab 18:126–131CrossRefPubMed Orimo H, Hashimoto T, Sakata K, Yoshimura N, Suzuki T, Hosoi T (2000) Trends in the incidence of hip fracture in Japan, 1987–1997: the third nationwide survey. J Bone Miner Metab 18:126–131CrossRefPubMed
5.
go back to reference Orimo H, Yaegashi Y, Onoda T, Fukushima Y, Hosoi T, Sakata K (2009) Hip fracture incidence in Japan: estimates of new patients in 2007 and 20 year trends. Arch Osteoporos 4:71–77CrossRefPubMedPubMedCentral Orimo H, Yaegashi Y, Onoda T, Fukushima Y, Hosoi T, Sakata K (2009) Hip fracture incidence in Japan: estimates of new patients in 2007 and 20 year trends. Arch Osteoporos 4:71–77CrossRefPubMedPubMedCentral
6.
go back to reference Orimo H, Yaegashi Y, Onoda T, Fukushima Y, Hashimoto T, Hosoi T, Sakata K (2016) Hip fracture incidence in Japan: Estimates of new patients in 2012 and 25-year trends. Osteoporos Int. [Epub ahead of print] Orimo H, Yaegashi Y, Onoda T, Fukushima Y, Hashimoto T, Hosoi T, Sakata K (2016) Hip fracture incidence in Japan: Estimates of new patients in 2012 and 25-year trends. Osteoporos Int. [Epub ahead of print]
7.
go back to reference Statistics Bureau, Ministry of Internal Affairs and Communications, Statistics Japan. Population estimates by age (5 year age group) and gender (final estimates), 1 January 2012 Statistics Bureau, Ministry of Internal Affairs and Communications, Statistics Japan. Population estimates by age (5 year age group) and gender (final estimates), 1 January 2012
8.
go back to reference Moriwaki K, Komaba H, Noto S, Yanagisawa S, Takiguchi T, Inoue H, Toujo T, Fukagawa M, Takahashi HE (2013) Cost-effectiveness of alendronate for the treatment of osteopenic postmenopausal women in Japan. J Bone Miner Res 28:395–403CrossRefPubMed Moriwaki K, Komaba H, Noto S, Yanagisawa S, Takiguchi T, Inoue H, Toujo T, Fukagawa M, Takahashi HE (2013) Cost-effectiveness of alendronate for the treatment of osteopenic postmenopausal women in Japan. J Bone Miner Res 28:395–403CrossRefPubMed
Metadata
Title
Decreased rate of hip fracture and consequent reduction in estimated medical costs in Japan
Authors
Hiroaki Ohta
Mitsuko Mouri
Tatsuhiko Kuroda
Toshitaka Nakamura
Masataka Shiraki
Hajime Orimo
Publication date
01-05-2017
Publisher
Springer Japan
Published in
Journal of Bone and Mineral Metabolism / Issue 3/2017
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-016-0760-0

Other articles of this Issue 3/2017

Journal of Bone and Mineral Metabolism 3/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.